TUPEC18 | Empowering adolescent school girls with SKILLZ: 6-month follow-up results from a cluster randomized trial in Lusaka, Zambia | Poster exhibition | HIV testing |
EPD0572 | Empathy-based training of HIV treatment peer supporters improves performance and reduces treatment interruptions: experience from the I CAN Campaign in Malawi | E-poster | Social and behavioural aspects and approaches to HIV |
TUPEA05 | Emergence of genetically-distinct HIV-1 populations is associated with transient virological control during analytical interruption of antiretroviral therapy | Poster exhibition | Understanding and targeting persistent HIV reservoirs |
EPC0462 | Elimination through Inclusion: capacity building of community health workers, improvement in supply chain, data recording and reporting system resulted in improved PMTCT outcomes: innovation from Global fund supported Ahana project | E-poster | HIV testing |
EPA0016 | Elevated plasma galectin-9 among vertically infected youth with HIV on ART is associated with Iinflammation and cognitive performance | E-poster | HIV pathogenesis |
EPC0306 | Elevated homocysteine may mediate the association of HIV with subclinical coronary atherosclerosis among middle-aged adults | E-poster | Epidemiology of HIV |
EPB0190 | eGFR change after transitioning to DTG-based ART at Newlands Clinic in Zimbabwe: a cohort study | E-poster | Clinical complications of HIV and antiretroviral therapy |
TUPEB02 | Efficacy of dolutegravir plus lamivudine in treatment-naive people living with HIV without baseline drug-resistance testing: week 24 results of the randomized D2ARLING study | Poster exhibition | Antiretroviral therapies and clinical issues in adults |
TUPEE08 | Efficacy of a multi-level pilot intervention to reduce discrimination faced by MSM and transgender women in public hospitals in India: findings from a pre-/post-test quasi-experimental trial among healthcare workers | Poster exhibition | Health systems, health systems strengthening and partnerships |
TUPEB03 | Efficacy and safety of switching older adults (≥60 years) from first-line art to B/F/TAF in Kenya - a randomized clinical trial (the B/F/TAF elderly study) | Poster exhibition | Antiretroviral therapies and clinical issues in adults |